000259757 001__ 259757
000259757 005__ 20240403123609.0
000259757 0247_ $$2doi$$a10.3390/jcm12155012
000259757 0247_ $$2pmid$$apmid:37568414
000259757 0247_ $$2pmc$$apmc:PMC10419929
000259757 037__ $$aDZNE-2023-00791
000259757 041__ $$aEnglish
000259757 082__ $$a610
000259757 1001_ $$0P:(DE-2719)9001603$$aFries, Franca Laura$$b0$$eFirst author$$udzne
000259757 245__ $$aDiagnosis of Froin's Syndrome by Parallel Analysis of Ventriculoperitoneal Shunt and Lumbar Cerebrospinal Fluid in a Patient with Cervical Spinal Stenosis.
000259757 260__ $$aBasel$$bMDPI$$c2023
000259757 3367_ $$2DRIVER$$aarticle
000259757 3367_ $$2DataCite$$aOutput Types/Journal article
000259757 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1694088313_1590
000259757 3367_ $$2BibTeX$$aARTICLE
000259757 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000259757 3367_ $$00$$2EndNote$$aJournal Article
000259757 520__ $$aElevated protein levels in cerebrospinal fluid (CSF) can occur in various pathologies and are sometimes difficult to interpret. We report a 62-year-old male patient with subacute neurological deterioration, progressive tetraparesis, and cytoalbumin dissociation in the lumbar CSF. The patient had a pre-existing cervical spinal stenosis with mild tetraparesis. Based on the initial cytoalbumin dissociation (protein 938 mg/dL, 4 leucocytes/µL), Guillain-Barré syndrome was initially considered. For further diagnosis, a CSF sample was taken from a pre-existing ventriculoperitoneal shunt, which showed a normal protein and cell count considering the patient's age (protein 70 mg/dL, 1 leucocyte/µL). In conclusion, we suggest that intermediate aggravation of tetraparesis was due to pneumonia with septic constellation, and the cytoalbumin dissociation was interpreted as Froin's syndrome (FS) due to spinal stenosis. In this unique case, we were able to prove the -often suspected- case of FS by parallel analysis of ventriculoperitoneal shunt and lumbar CSF. The triad of xanthochromia, high protein levels, and marked coagulation was first described by Georges Froin and occurs in various processes leading to severe spinal stenosis. The altered composition of lumbar CSF might be due to impaired CSF circulation; however, the exact mechanisms of this phenomenon require further investigation.
000259757 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000259757 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000259757 650_7 $$2Other$$aFroin’s syndrome
000259757 650_7 $$2Other$$aFroin’s syndrome
000259757 650_7 $$2Other$$aFroin’s syndrome
000259757 650_7 $$2Other$$aFroin’s syndrome
000259757 650_7 $$2Other$$acervical spinal stenosis
000259757 650_7 $$2Other$$aelevated CSF protein
000259757 650_7 $$2Other$$alumbar puncture
000259757 650_7 $$2Other$$aventriculoperitoneal shunt
000259757 7001_ $$00000-0002-7575-0020$$aKleiser, Benedict$$b1
000259757 7001_ $$aSchwarz, Patricia$$b2
000259757 7001_ $$aTieck, Maria P$$b3
000259757 7001_ $$00000-0002-8722-4255$$aLaichinger, Kornelia$$b4
000259757 7001_ $$00000-0002-2399-3020$$aMengel, Annerose$$b5
000259757 7001_ $$00000-0001-8372-3615$$aZiemann, Ulf$$b6
000259757 7001_ $$aKowarik, Markus C$$b7
000259757 770__ $$aAdvances in the Diagnosis and Treatment of Brain Damage)
000259757 773__ $$0PERI:(DE-600)2662592-1$$a10.3390/jcm12155012$$gVol. 12, no. 15, p. 5012 -$$n15$$p5012$$tJournal of Clinical Medicine$$v12$$x2077-0383$$y2023
000259757 8564_ $$uhttps://pub.dzne.de/record/259757/files/DZNE-2023-00791.pdf$$yOpenAccess
000259757 8564_ $$uhttps://pub.dzne.de/record/259757/files/DZNE-2023-00791.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000259757 909CO $$ooai:pub.dzne.de:259757$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000259757 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001603$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000259757 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000259757 9141_ $$y2023
000259757 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-17
000259757 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000259757 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-17
000259757 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-17
000259757 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000259757 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-17
000259757 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN MED : 2022$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T14:59:21Z
000259757 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T14:59:21Z
000259757 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-04-12T14:59:21Z
000259757 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-25
000259757 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-25
000259757 9201_ $$0I:(DE-2719)1210000$$kAG Gasser$$lParkinson Genetics$$x0
000259757 980__ $$ajournal
000259757 980__ $$aVDB
000259757 980__ $$aUNRESTRICTED
000259757 980__ $$aI:(DE-2719)1210000
000259757 9801_ $$aFullTexts